In conclusion, this study provides evidence for CB1R transport by exosomes and suggests that the in vitro effects of circulating exosomes from NAFLD patients are mediated by the expression of cannabinoid receptors. The gene discussed is CNR1; the disease is metabolic dysfunction-associated steatotic liver disease.